Results 101 to 110 of about 1,203 (203)

Autoinflammatory keratinization diseases: An emerging concept encompassing various inflammatory keratinization disorders of the skin [PDF]

open access: yes, 2018
Classifying inflammatory skin diseases is challenging, especially for the expanding group of disorders triggered by genetic factors resulting in hyperactivated innate immunity that result in overlapping patterns of dermal and epidermal inflammation with ...
Akiyama, Masashi   +3 more
core   +3 more sources

Pripravci ljekovitih biljaka u liječenju kožnih bolesti [PDF]

open access: yes, 2016
Botanical data, chemical composition and use of the most common medicinal plants preparations in the treatment of skin diseases are presented in this article.
Jakupović, Lejsa   +2 more
core   +1 more source

Expanding the therapeutic horizons of spesolimab: a review of off-label applications for inflammatory skin diseases

open access: yesJournal of Dermatological Treatment
Purpose This review aims to outline the crucial role of IL-36 signaling in inflammatory skin diseases and summarize the therapeutic potential of spesolimab.
Hanlin Zhang   +4 more
doaj   +1 more source

Evaluation of Serum Interleukin-33 and Tumor Necrosis Factor-α Levels in Patients with Psoriasis: Correlation with Disease Severity [PDF]

open access: yes
Psoriasis is an immune-mediated dermatological disorder marked by accelerated skin cell proliferation, leading to thickened, rough, scaly lesions capable of causing itching, discomfort, and inflammation.
Hassan, Ali Hussein   +1 more
core   +3 more sources

EXISTING AND NOVEL THERAPIES FOR PSORIASIS [PDF]

open access: yes, 2018
Psoriasis is adjudged as prototypic papulosquamous skin condition attributed by the erythematous papules (or) plaques. It occurs at any age but commonly seen in age groups of 20–30 and 50–60 years. Psoriasis affects around 2% of the world population.
Jain, Gaurav K   +2 more
core   +1 more source

Low grade of satisfaction related to the use of current systemic therapies among pustular psoriasis patients: a therapeutic unmet need to be fulfilled

open access: yesFrontiers in Medicine
IntroductionPustular psoriasis is considered a separate entity from plaque psoriasis and can be categorized as generalized pustular psoriasis (GPP), acrodermatitis continua of Hallopeau, or palmoplantar pustulosis (PPP). Current guidelines mostly include
Giulia Coscarella   +19 more
doaj   +1 more source

Certolizumab Pegol: A New Therapeutic Approach for Acrodermatitis Continua of Hallopeau. [PDF]

open access: yesSkin Appendage Disord, 2022
Rizzetto G   +4 more
europepmc   +1 more source

Experiencia en el Hospital Universitario Basurto con secukinumab para el tratamiento de la psoriasis moderada-grave [PDF]

open access: yes, 2018
[ES] Hemos realizado un estudio descriptivo retrospectivo para valorar la respuesta y la seguridad del tratamiento con secukinumab, un biológico anti IL-17, durante 52 semanas en pacientes con psoriasis moderada-grave.
Orbea Sopeña, Ana
core  

Home - About - Disclaimer - Privacy